Bausch + Lomb Overview
Update this profile
Share Price
$17.45
(As of Friday Closing)
Bausch + Lomb General Information
Description
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.
Contact Information
Want to dig into this profile?
We’ll help you find what you need
Learn more
Bausch + Lomb Stock Performance
(As of Friday Closing)
Stock Price
Previous Close
52 wk Range
Market Cap
Shares
Average Volume
EPS
$17.45
$17.60
$12.44 - $20.07
$6.11B
350M
4.32K
$0.17
Bausch + Lomb Financials Summary
In Thousands, USD
TTM
30-Sep-2022
FY 2021
31-Dec-2021
FY 2020
31-Dec-2020
FY 2019
31-Dec-2019
EV
7,523,557
Revenue
3,773,000
3,765,000
3,412,000
3,778,000
EBITDA
643,000
733,000
729,000
867,000
Net Income
58,000
182,000
(18,000)
298,000
Total Assets
10,696,000
10,823,000
11,266,000
11,468,000
Total Debt
2,438,000
0
0
0
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Bausch + Lomb Valuation & Funding
Deal Type
Date
Amount
Valuation/ EBITDA
Post-Val
Status
Debt
This information is available in the PitchBook Platform. To explore Bausch + Lomb‘s full profile, request access.
Request a free trial
Bausch + Lomb Comparisons
Description
Primary Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United
Therapeutic Devices
Bridgewater, NJ
12,800
As of 2022
00000
0.00
0000-00-00
00000000
00000
o eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim v
00000000000 0000000
Aliso Viejo, CA
000
As of 0000
00000
0000
0000-00-00
00000000
00000
mmodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
00000000000 0000000
Charenton-le-Pont, France
000000
As of 0000
000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trial
Bausch + Lomb Competitors (6)
Company Name
Financing Status
Location
Employees
Total Raised
Last Financing Date/Type
Last Financing Amount
RxSight
Formerly VC-backed
Aliso Viejo, CA
000
00000
00000000
00000
0000000
Corporation
Charenton-le-Pont, France
000000
000000000
0000000000
Formerly VC-backed
Carlsbad, CA
00
000.00
000000&0
000.00
000000
Formerly VC-backed
Mountain View, CA
000
000.00
000000000 -
000.00
00000000
Formerly VC-backed
Irvine, CA
00
0000
000000&0
0000
To view Bausch + Lomb’s complete competitors history, request access »
Bausch + Lomb Patents
7,488
Total Documents
Applications and Grants
000
Total Patents
Families
227
Granted
24
Pending
000
Expiring
in next 12 mo
Bausch + Lomb Recent Patent Activity
Publication ID
Patent Title
Status
First Filing Date
Technology (CPC)
Citations
US-20200375681-A1
Detachable finger-activated surgical control device
Inactive
03-Jun-2019
000000000
CA-3132335-A1
Glycophospholipid polymeric network and use thereof
Pending
29-Apr-2019
00000000000
EP-3962961-A1
Glycophospholipid polymeric network and use thereof
Pending
29-Apr-2019
00000000000
JP-2022530253-A
Glycophospholipid polymer network and its use
Pending
29-Apr-2019
00000000000
US-20200339710-A1
Glycophospholipid polymeric network and use thereof
Pending
29-Apr-2019
C08B37/0063
0
To view Bausch + Lomb’s complete patent history, request access »
Bausch + Lomb Executive Team (34)
Update this profile
Name
Title
Board Seat
Contact Info
Joseph Papa
Chief Executive Officer & Board Member
Joseph Gordon
President, Global Consumer, Surgical and Vision Care
Kelly Webber
Chief Human Resources Officer & Executive Vice President
Louis Yu Ph.D
Chief Quality Officer & Executive Vice President
David Fisher
Executive Director, Marketing, US & Global Marketing Head (Anti-Infective/Allergy)
You’re viewing 5 of 34 executive team members. Get the full list »
Bausch + Lomb Signals
Growth Rate
0.80%
Weekly Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial
Bausch + Lomb Investors
Investor Name
Investor Type
Holding
Investor Since
Participating Rounds
Contact Info
This information is available in the PitchBook Platform. To explore Bausch + Lomb‘s full profile, request access.
Request a free trial
Bausch + Lomb
Investments & Acquisitions (27)
Company Name
Deal Date
Deal Type
Deal Size
Industry
Lead Partner
00000000
17-Jan-2023
0000000000
Therapeutic Devices
000000 00
000000000
27-Jul-2022
00000 0000
0000
Surgical Devices
000000 00
00000 0000000
12-Jan-2016
0000000000
Therapeutic Devices
0000 0000
000000'0 0000
23-Oct-2015
0000000000
Diagnostic Equipment
00000 000
Innovative Sclerals
24-Apr-2015
Merger/Acquisition
Therapeutic Devices
000 00000
You’re viewing 5 of 27 investments and acquisitions. Get the full list »